642 ©2011 Society For Biomaterials

............................................................................................................................................................................... 623 Introduction .......................................................................................................................................................................... 624 Case Study Sites ...............

Mass Radiography E. J. C. Kendall, M.D., and others; G. N. W. Tilsley, M.B., and W. E. Greaves, M.B.; D. R. Wallace-Jones, D.M.R.D., and M. Goldm an, D.M.R.D. ........ ......................495 Investigations in Enuretic Children D. M. T. Gairdner, F.R.C.P. 496 Mentally Subnormal Children B. D. J. Leary, .B. ........................ 496 Transmission of Toxoplasmosis J. H. E. Th. Meuwissen, M.D....

OBJECTIVE To determine if cardiopulmonary bypass (CPB), together with inhibition of the sodium-hydrogen exchanger (NHE), limits myocardial and neurological injury and improves recovery after prolonged (unwitnessed) cardiac arrest (CA), as NHE inhibition improved recovery after deep hypothermic circulatory arrest. METHODS Twenty-seven pigs (31-39 kg) underwent 15 min of prolonged (no-flow) CA ...

Department of Human Evolutionary Biology, Harvard University, Cambridge, MA; Nutrition Laboratory, Smithsonian National Zoological Park, Washington, DC; Brain, Mind, and Behavior Unit, California National Primate Research Center, Davis CA, USA *Corresponding author. Department of Human Evolutionary Biology, Harvard University, 11 Divinity Avenue, Cambridge, MA 02138, USA. Tel: 617-496-4551; Fax...

Running Title: Mapping the dimerization domain of SARS-CoV N protein Department of Biological Sciences and the Cancer Center, † Bindley Biosciences Center, Purdue University, West Lafayette, IN 47907 State Key Lab for Biocontrol, Zhongshan University, Guangzhou, P.R.China To whom correspondence should be addressed: Department of Biological Sciences, Purdue University, West Lafayette, IN 47907-1...

Chemical substitutions in the structure of the pyrimido-pyrimidine nucleus give rise to pyrimidopyrimidine compounds with platelet antiaggregatory effects, such as RA-8 (dipyridamole), RA233 (mopidamol) and RA-642. All these compounds inhibit platelet aggregation-induced by ADP through an increase in platelet CAMP levels (1,2). Mopidamol, however, is 3-10 times more potent than dipyridamole and...